Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | -5.88% | -14.56% | -74.93% |
Financials (USD)
Sales 2024 * | 428K | Sales 2025 * | 300K | Capitalization | 5.45M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -33M | EV / Sales 2024 * | 12.7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 18.2 x |
P/E ratio 2024 * |
-0.37
x | P/E ratio 2025 * |
-0.45
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.2% |
Latest transcript on TFF Pharmaceuticals, Inc.
1 day | -5.88% | ||
1 week | -14.56% | ||
Current month | -14.56% | ||
1 month | -20.00% | ||
3 months | -78.64% | ||
6 months | -79.89% | ||
Current year | -74.93% |
Managers | Title | Age | Since |
---|---|---|---|
Harlan Weisman
CEO | Chief Executive Officer | 71 | 18-11-30 |
Kirk Coleman
DFI | Director of Finance/CFO | 51 | 18-01-23 |
Zamaneh Mikhak
CTO | Chief Tech/Sci/R&D Officer | 58 | 23-01-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 52 | 18-11-30 | |
Brandi Roberts
BRD | Director/Board Member | 50 | 22-03-24 |
Thomas King
BRD | Director/Board Member | 69 | Dec. 12 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.76 | -5.88% | 21,026 |
24-06-06 | 1.87 | -3.51% | 44,734 |
24-06-05 | 1.938 | -5.00% | 137,993 |
24-06-04 | 2.04 | -4.23% | 17,151 |
24-06-03 | 2.13 | +3.40% | 11,363 |
Delayed Quote Nasdaq, June 07, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-74.93% | 5.45M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- TFFP Stock